Viagra doesn't cause skin cancer, shows study

Image
IANS New York
Last Updated : Jun 25 2015 | 12:28 PM IST

Lifestyle factors, not Viagra, put users of erectile dysfunction drugs at higher risk of melanoma, a deadly form of skin cancer, says a study.

The study that involved analysis of medical records of over 20,235 men concluded that use of erectile dysfunction drugs does not cause melanoma and that the likely source of the observed uptick in malignant melanoma risk among users of erectile dysfunction drugs is socioeconomic and lifestyle based.

"When used appropriately, such medications are very effective and improve the quality of life of many men, so men should know it is doubtful that taking these medications puts them at greater risk of getting skin cancer," said lead study author Stacy Loeb from New York University Langone Medical Center.

"What our study results show is that groups of men who are more likely to get malignant melanoma include those with higher disposable incomes and education -- men who likely can also afford more vacations in the sun -- and who also have the means to buy erectile dysfunction medications, which are very expensive."

Among more than 20,000 men whose records were studied, 4,065 were found to have malignant melanoma between 2006 and 2012.

Among these men were 2,148 who had used any of the three main drugs for erectile dysfunction -- Viagra (also known as sildenafil), Levitra (vardenafil) and Cialis (tadalafil) -- and among them, some 435 had the skin cancer.

Researchers who led the analysis said while there was a greater statistical risk of developing malignant melanoma among erectile dysfunction drug users (an overall increased risk of 21 percent for having filled a single prescription), a closer look at the numbers revealed no increased risk among those men with the most prescriptions.

"While medications for erectile dysfunction come with serious risk of a drop in blood pressure if taken together with other medicines called nitrates, overall they are safe medications and our results suggest that physicians should not be concerned that the drugs cause melanoma," Loeb said.

The results appeared online in the Journal of the American Medical Association.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 25 2015 | 12:20 PM IST

Next Story